JP2009051756A - Bactericidal composition - Google Patents
Bactericidal composition Download PDFInfo
- Publication number
- JP2009051756A JP2009051756A JP2007218888A JP2007218888A JP2009051756A JP 2009051756 A JP2009051756 A JP 2009051756A JP 2007218888 A JP2007218888 A JP 2007218888A JP 2007218888 A JP2007218888 A JP 2007218888A JP 2009051756 A JP2009051756 A JP 2009051756A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- group
- mass
- disinfectant composition
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
本発明は、食品加工機、厨房機器、医療機器及びその周辺設備を殺菌洗浄するための殺菌剤組成物及びこれを用いた殺菌方法に関する。 The present invention relates to a bactericide composition for sterilizing and washing food processing machines, kitchen equipment, medical equipment and peripheral equipment, and a sterilization method using the same.
現在、殺菌や消毒目的で使用される薬剤にはさまざまなものが知られているが、特に塩素系殺菌剤として次亜塩素酸ナトリウムや酸素系殺菌剤である過酸化水素や水中で過酸化水素を発生する過炭酸塩、過ホウ酸塩等が主として用いられている。しかしながらこれらの殺菌剤は種々の課題を有している。例えば次亜塩素酸ナトリウムは炭酸カルシウム等のスケール汚れを除去できないし、金属に対し腐食性であり、酸性物質との混合によって塩素ガスを発生するという取り扱い上の問題がある。過酸化水素は高度の殺菌効果を得るためには高濃度で長時間作用させる必要がある。4級アンモニウム塩は低pH領域で殺菌力が低下し、細菌芽胞やカビ類に無効である。またたんぱく質によって失活するので事前の洗浄が必要である。例えば人工血液透析装置の透析液流路を殺菌洗浄するには、細菌芽胞を含む微生物を死滅でき、スケール汚れとたんぱく質汚れを除去できる薬剤が要求される。現在、透析液流路の殺菌洗浄は次亜塩素酸ナトリウムと酢酸のような2種類以上の薬剤を組み合わせた複雑な方法で行われている。 Currently, there are various known chemicals used for sterilization and disinfection purposes. Especially, sodium hypochlorite, oxygen-based disinfectant hydrogen peroxide, and hydrogen peroxide in water. Percarbonates, perborates and the like that generate water are mainly used. However, these fungicides have various problems. For example, sodium hypochlorite has a problem in handling that it cannot remove scale dirt such as calcium carbonate, is corrosive to metals, and generates chlorine gas when mixed with an acidic substance. Hydrogen peroxide needs to act for a long time at a high concentration in order to obtain a high degree of bactericidal effect. Quaternary ammonium salts have low bactericidal activity at low pH and are ineffective against bacterial spores and molds. In addition, since it is inactivated by protein, prior cleaning is required. For example, in order to sterilize and wash the dialysate flow path of an artificial hemodialysis apparatus, a drug that can kill microorganisms including bacterial spores and remove scale dirt and protein dirt is required. At present, sterilization cleaning of the dialysate flow path is performed by a complicated method in which two or more kinds of drugs such as sodium hypochlorite and acetic acid are combined.
特許文献1には、可食性の酸を添加した、ダイマー型ビス第四級アンモニウム塩の溶液を加温して被殺菌物に接触させることを特徴とする細菌芽胞の殺菌方法が開示されている。 Patent Document 1 discloses a method for sterilizing bacterial spores characterized by heating a solution of a dimer-type bis quaternary ammonium salt to which an edible acid is added and bringing the solution into contact with an object to be sterilized. .
また、特許文献2には、疎水性過酸及びカチオン界面活性剤を含有する水性組成物が開示されており、当該組成物はバチルス芽胞に対して有効であるとされている。
しかし、特許文献1では短時間での殺菌を目的としているが故に、高濃度の可食性の酸を必要とし(実施例では10重量%)、溶液を高温、例えば70〜80℃程度で使用する必要がある。また、塩化ベンザルコニウムとの組み合わせでは目的を達成できず、使用できる4級アンモニウム塩はダイマー型のものに限定される。特許文献2で用いられている過酸はカチオン界面活性剤が共存すると貯蔵安定性が悪く、使用時に2つの濃縮原液を混合する作業が必要となる。 However, since Patent Document 1 aims at sterilization in a short time, a high concentration of edible acid is required (10% by weight in the examples), and the solution is used at a high temperature, for example, about 70 to 80 ° C. There is a need. In addition, the combination with benzalkonium chloride cannot achieve the purpose, and the quaternary ammonium salt that can be used is limited to the dimer type. The peracid used in Patent Document 2 has poor storage stability when a cationic surfactant coexists, and it is necessary to mix two concentrated stock solutions at the time of use.
本発明の目的は、細菌芽胞に対して優れた殺菌効果を示し、例えば106cfu/mLの濃度の細菌芽胞を死滅させることができ、同時にたんぱく質汚れやスケール汚れを除去できる殺菌剤組成物を提供することにある。またそのような殺菌剤組成物を用いた殺菌方法を提供することにある。 An object of the present invention is to provide a bactericidal composition that exhibits an excellent bactericidal effect on bacterial spores, for example, can kill bacterial spores at a concentration of 10 6 cfu / mL, and at the same time remove protein stains and scale stains. It is to provide. Moreover, it is providing the sterilization method using such a disinfectant composition.
本発明は、(A)有機カルボン酸、〔以下、(A)成分という〕(B)無機酸〔以下、(B)成分という〕及び(C)4級アンモニウム塩〔以下、(C)成分という〕を含有する殺菌剤組成物に関する。また、本発明は、かかる本発明の殺菌剤組成物を、10℃以上60℃以下の温度にして対象物に接触させる殺菌方法に関する。 The present invention includes (A) an organic carboxylic acid (hereinafter referred to as component (A)), (B) an inorganic acid (hereinafter referred to as component (B)) and (C) a quaternary ammonium salt (hereinafter referred to as component (C). ] It is related with the disinfectant composition containing this. The present invention also relates to a sterilization method in which the disinfectant composition of the present invention is brought into contact with an object at a temperature of 10 ° C. or more and 60 ° C. or less.
本発明によれば、細菌芽胞に対する殺菌効果が高く、例えば106cfu/mL以上の濃度の細菌芽胞を死滅させることができる殺菌剤組成物が得られる。また、本発明の殺菌剤組成物は、たんぱく質汚れやスケール汚れに対する洗浄効果にも優れる。 ADVANTAGE OF THE INVENTION According to this invention, the bactericidal effect with respect to a bacterial spore is high, for example, the bactericidal composition which can kill the bacterial spore of the density | concentration of 10 < 6 > cfu / mL or more is obtained. Moreover, the disinfectant composition of the present invention has an excellent cleaning effect against protein stains and scale stains.
本発明の殺菌剤組成物を用いた殺菌方法によれば、種々の食品加工機、厨房機器、医療機器及びその周辺設備の微生物を殺菌することができる。例えば細菌類では、大腸菌、サルモネラ菌、黄色ブドウ球菌、緑膿菌、真菌類では黒コウジカビ、カンジダ菌等が挙げられる。更には殺菌剤に強い抵抗性を示し、耐熱性を有する枯草菌等の細菌芽胞や黒コウジカビ、カンジダ菌等の真菌胞子を死滅させることが重要である。このうち細菌芽胞とは、増殖に適さない環境において作られる休眠細胞であり、菌体の外側には多重の層状外殻を有しており、薬剤や熱に対する抵抗性が高い。しかし、本発明の殺菌剤組成物では、これらの細菌芽胞に対しても高い殺菌効果が得られる。その際、たんぱく質汚れとスケール汚れに対しても優れた除去効果が得られる。 According to the sterilization method using the bactericide composition of the present invention, it is possible to sterilize microorganisms in various food processing machines, kitchen equipment, medical equipment and peripheral equipment. Examples of bacteria include Escherichia coli, Salmonella, Staphylococcus aureus, Pseudomonas aeruginosa, and fungi such as Aspergillus niger and Candida. Furthermore, it is important to kill bacterial spores such as Bacillus subtilis and fungi spores such as Aspergillus niger and Candida that exhibit strong resistance to bactericides and have heat resistance. Bacterial spores are dormant cells produced in an environment unsuitable for growth, and have multiple layered outer shells on the outside of the cells, which are highly resistant to drugs and heat. However, the bactericidal composition of the present invention provides a high bactericidal effect against these bacterial spores. At that time, an excellent removal effect can be obtained against protein stains and scale stains.
<(A)成分>
有機カルボン酸としては、蟻酸、酢酸、プロピオン酸及び酪酸等の炭素数1から4の脂肪族一価カルボン酸、グリコール酸、クエン酸、リンゴ酸、酒石酸、乳酸、グルコン酸等の炭素数2から6の脂肪族ヒドロキシカルボン酸、シュウ酸、マロン酸、マレイン酸等の炭素数2から4の脂肪族二価カルボン酸が例示できる。なかでも、グリコール酸、クエン酸、リンゴ酸、乳酸、及び酒石酸からなる群より選ばれる1種以上が、殺菌性とたんぱく質汚れ除去性の観点から好ましい。本発明において、(A)成分は、殺菌とたんぱく質汚れの除去に寄与する成分である。
<(A) component>
Examples of the organic carboxylic acid include aliphatic monovalent carboxylic acids having 1 to 4 carbon atoms such as formic acid, acetic acid, propionic acid, and butyric acid, glycol acids, citric acid, malic acid, tartaric acid, lactic acid, gluconic acid, etc. Examples thereof include aliphatic dicarboxylic carboxylic acids having 2 to 4 carbon atoms such as 6 aliphatic hydroxycarboxylic acids, oxalic acids, malonic acids, and maleic acids. Among these, at least one selected from the group consisting of glycolic acid, citric acid, malic acid, lactic acid, and tartaric acid is preferable from the viewpoint of bactericidal properties and protein stain removability. In the present invention, the component (A) is a component that contributes to sterilization and removal of protein stains.
<(B)成分>
無機酸としては、塩酸、硫酸、硝酸及びリン酸からなる群より選ばれる1種以上が挙げられる。(B)成分は殺菌及びスケール除去に効果がある。
<(B) component>
Examples of the inorganic acid include one or more selected from the group consisting of hydrochloric acid, sulfuric acid, nitric acid, and phosphoric acid. Component (B) is effective for sterilization and scale removal.
<(C)成分>
4級アンモニウム塩としては、ベンゼトニウム塩、アルキルピリジニウム塩、または下記一般式(1)で示される化合物から選ばれる1種以上が好ましい。
R1R2R3R4N+X- 式(1)
〔式(1)中、R1、R2、R3及びR4のうち少なくとも1つは、アルコキシル基、アルカノイルアミノ基又はアルカノイルオキシ基で置換されていてもよい総炭素数8〜28のアルキル基又はアルケニル基を示し、残余はフェニル基、ベンジル基、炭素数1〜5のアルキル基、及び−(R5O)mH(ここでR5は炭素数2〜3のアルキレン基を示し、mは2〜40の数を示す)から選ばれる基を示す。X-はハロゲン原子又は有機性のアニオン基である。〕
<(C) component>
The quaternary ammonium salt is preferably at least one selected from a benzethonium salt, an alkylpyridinium salt, or a compound represented by the following general formula (1).
R 1 R 2 R 3 R 4 N + X - wherein (1)
[In the formula (1), at least one of R 1 , R 2 , R 3 and R 4 is alkyl having a total carbon number of 8 to 28 which may be substituted with an alkoxyl group, an alkanoylamino group or an alkanoyloxy group. A group or an alkenyl group, the remainder being a phenyl group, a benzyl group, an alkyl group having 1 to 5 carbon atoms, and — (R 5 O) m H (wherein R 5 represents an alkylene group having 2 to 3 carbon atoms, m represents a group selected from 2 to 40). X − represents a halogen atom or an organic anionic group. ]
中でも、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム、及び塩化アルキル(炭素数10〜22)トリメチルアンモニウムからなる群より選ばれる1種以上が殺菌性の観点から好ましい。更には塩化ベンザルコニウムがより好ましい。 Among these, at least one selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, and alkyl chloride (C10 to C22) trimethylammonium is preferable from the viewpoint of bactericidal properties. Furthermore, benzalkonium chloride is more preferable.
(C)成分は殺菌作用に効果がある。特に、(A)成分と(B)成分に、更に(C)成分を共存させることにより、殺菌作用において相乗効果が得られ、(A)成分、(B)成分及び(C)成分の合計の使用量を低減することができる。 Component (C) is effective for bactericidal action. In particular, by further coexisting the component (C) with the component (A) and the component (B), a synergistic effect is obtained in the bactericidal action, and the total of the components (A), (B) and (C) The amount used can be reduced.
<殺菌剤組成物>
有機カルボン酸は水中において解離型酸と非解離型酸として存在するが、本発明では、非解離型酸が発明の効果を発現する上で重要な役割を果たしている。本発明では、無機酸を併用することで、有機カルボン酸は水中で非解離型酸として存在するため殺菌効果が顕著に向上すると考えられる。
<Fungicide composition>
Organic carboxylic acids exist in water as dissociable acids and non-dissociable acids, but in the present invention, non-dissociable acids play an important role in expressing the effects of the invention. In the present invention, it is considered that by using an inorganic acid in combination, the organic carboxylic acid is present as a non-dissociable acid in water, so that the bactericidal effect is remarkably improved.
有機カルボン酸と無機酸が共存することはNaOH等による中和滴定曲線によって判断できる。即ち強酸である無機酸部分の中和変曲点と弱酸である有機カルボン酸部分の中和変曲点が二段階で観測されることから両者の存在が判る。また有機カルボン酸と無機酸の陰イオンは、それぞれ高速液体クロマトグラフィとイオンクロマトグラフィによって、その種類と濃度を知ることができる。 The coexistence of an organic carboxylic acid and an inorganic acid can be judged by a neutralization titration curve with NaOH or the like. That is, since the neutral inflection point of the inorganic acid portion that is a strong acid and the neutral inflection point of the organic carboxylic acid portion that is a weak acid are observed in two stages, the existence of both can be understood. In addition, the types and concentrations of the anions of the organic carboxylic acid and the inorganic acid can be known by high performance liquid chromatography and ion chromatography, respectively.
本発明の殺菌剤組成物は、(A)成分と(B)成分の質量比が(A)/(B)=0.1〜200、更に1〜50、特に5〜20であることが好ましい。また、(B)成分と(C)成分の質量比が(C)/(B)=0.1〜50、更に0.5〜20、特に1〜10であることが好ましい。 In the disinfectant composition of the present invention, the mass ratio of the component (A) to the component (B) is preferably (A) / (B) = 0.1 to 200, more preferably 1 to 50, and particularly preferably 5 to 20. . Moreover, it is preferable that mass ratio of (B) component and (C) component is (C) / (B) = 0.1-50, 0.5-20, especially 1-10.
使用時において、本発明の殺菌剤組成物は、(A)成分を0.1〜2.0質量%、更に0.4〜1.6質量%、特に0.8〜1.4質量%含有することが好ましい。また、(B)成分を0.01〜1.0質量%、更に0.05〜0.5質量%、特に0.08〜0.25質量%含有することが好ましい。また、(C)成分を0.02〜0.5質量%、更に0.05〜0.35質量%、特に0.1〜0.25質量%含有することが好ましい。これらの範囲において、より良好な殺菌効果が得られ、排水処理の負荷が低減でき、経済性も良好となる。また、(A)成分、(B)成分がこれらの範囲であると装置部材への影響も少ない。(A)〜(C)成分をこの濃度で含有する組成物は、そのまま殺菌、洗浄に供することができる。このような濃度を満たした上で、当該殺菌剤組成物は、洗浄温度でのpHが0.1〜3であることが好ましい。更には、使用時の本発明のpHは、好ましくは有機カルボン酸のpKa値以下、もし有機多価カルボン酸或いは複数種類の有機カルボン酸を用いる場合は、それらの有機カルボン酸のうち最も小さいpKa値以下、より好ましくは、最も小さい該pKa値から更に0.5を引いた値以下であることが好ましい。 At the time of use, the fungicide composition of the present invention contains the component (A) in an amount of 0.1 to 2.0% by mass, further 0.4 to 1.6% by mass, particularly 0.8 to 1.4% by mass. It is preferable to do. Moreover, it is preferable to contain (B) component 0.01-1.0 mass%, 0.05-0.5 mass%, especially 0.08-0.25 mass%. Moreover, it is preferable to contain (C) component 0.02-0.5 mass%, 0.05-0.35 mass%, especially 0.1-0.25 mass%. In these ranges, a better sterilizing effect can be obtained, the load of wastewater treatment can be reduced, and the economic efficiency is also improved. Further, when the component (A) and the component (B) are within these ranges, the influence on the apparatus member is small. The composition containing the components (A) to (C) at this concentration can be directly subjected to sterilization and washing. After satisfying such a concentration, the disinfectant composition preferably has a pH at a washing temperature of 0.1 to 3. Furthermore, the pH of the present invention at the time of use is preferably not higher than the pKa value of the organic carboxylic acid. If an organic polyvalent carboxylic acid or a plurality of types of organic carboxylic acids are used, the smallest pKa of those organic carboxylic acids is used. It is preferable that it is not more than a value, more preferably not more than a value obtained by further subtracting 0.5 from the smallest pKa value.
本発明の殺菌剤組成物は、高濃度の殺菌剤原液として提供されてもよく、該原液を使用時に水で希釈して殺菌剤組成物、好ましくは上記使用時の濃度で(A)〜(C)成分を含有する殺菌剤組成物を調製することができる。殺菌剤原液として使用できる高濃度の殺菌剤組成物は、(A)成分を10〜60質量%、(B)成分を0.1〜10質量%、及び(C)成分を0.1〜30質量%含有することが好ましく、更には(A)成分を30〜50質量%、(B)成分を2〜8質量%及び(C)成分を2〜20質量%含有することが好ましく、特には(A)成分を35〜45質量%(B)成分を3〜6質量%及び(C)成分を5〜15質量%含有することが好ましい。これらの範囲において、取り扱い易く、安定性にも優れる。このような高濃度の殺菌剤組成物は、希釈して使用するための組成物であり、通常、10〜150倍に希釈して使用される。 The disinfectant composition of the present invention may be provided as a high-concentration disinfectant stock solution, and the stock solution is diluted with water at the time of use to disinfect the disinfectant composition, preferably at the concentration at the time of use (A) to (A C) A fungicidal composition containing the component can be prepared. The high-concentration fungicide composition that can be used as a bactericide stock solution has a component (A) of 10 to 60% by mass, a component (B) of 0.1 to 10% by mass, and a component (C) of 0.1 to 30%. Preferably, the component (A) is contained in an amount of 30 to 50% by mass, the component (B) is contained in an amount of 2 to 8% by mass, and the component (C) is preferably contained in an amount of 2 to 20% by mass. The component (A) is preferably 35 to 45% by mass, the component (B) is 3 to 6% by mass, and the component (C) is preferably 5 to 15% by mass. In these ranges, it is easy to handle and excellent in stability. Such a high-concentration disinfectant composition is a composition for use after dilution, and is usually diluted 10 to 150 times.
本発明の殺菌剤組成物は、食品加工機、厨房機器、医療機器及びその周辺設備を殺菌洗浄するために使用できる。医療機器としては、人工血液透析装置(その周辺機器等を含む)、内視鏡及び生検鉗子等の内視鏡用器具等の他、剪刀類、ピンセット類、鉗子類、持針器、膣鏡、レトラクター、蛇管、チューブ、カテーテル、カート等が挙げられる。特に、本発明の殺菌剤組成物は、人工血液透析装置用として好適である。 The disinfectant composition of the present invention can be used for sterilizing and washing food processing machines, kitchen equipment, medical equipment and peripheral equipment. Medical devices include artificial hemodialyzers (including peripheral devices), endoscopes and biopsy forceps, as well as scissors, tweezers, forceps, needle holders, vagina Examples include mirrors, retractors, serpentine tubes, tubes, catheters, carts, and the like. In particular, the bactericidal composition of the present invention is suitable for an artificial hemodialysis apparatus.
人工血液透析装置を対象とする場合、殺菌に加えて透析液組成由来の炭酸カルシウム分を除去し、さらに透析によって血液から取り除かれたたんぱく質汚れを洗浄することが要求される。内視鏡の場合も殺菌とたんぱく質汚れの除去が要求され、本発明の殺菌剤組成物の適応対象となる。 In the case of an artificial hemodialysis apparatus, in addition to sterilization, it is required to remove calcium carbonate derived from the dialysate composition and to wash away protein stains removed from blood by dialysis. Endoscopes are also required for sterilization and removal of protein stains, and are applicable to the disinfectant composition of the present invention.
本発明の殺菌剤組成物は、上記(A)〜(C)成分、更に本発明の効果を妨げない範囲でその他の成分を含有し、水を含有する液状の組成物とすることができる。その他の成分として、防錆剤、消泡剤、色素及び香料が挙げられる。 The disinfectant composition of the present invention can contain the above components (A) to (C) and other components as long as the effects of the present invention are not hindered, and can be a liquid composition containing water. Examples of other components include rust preventives, antifoaming agents, pigments, and fragrances.
本発明の殺菌剤組成物を医療機器、例えば人工血液透析装置に用いる場合、各種のフィルター材料との相互作用を考慮すると、(C)成分以外の界面活性剤を含有しないことが好ましい。 When the bactericide composition of the present invention is used in a medical device such as an artificial hemodialysis machine, it is preferable not to contain any surfactant other than the component (C) in consideration of the interaction with various filter materials.
本発明の殺菌剤組成物は、該組成物を10℃以上60℃以下の温度にして対象物に接触させる殺菌方法に供せられる。その際、本発明の殺菌剤組成物は、そのまま、或いは、上記のような高濃度の殺菌剤原液を水で希釈して得た組成物として、好ましくは(A)〜(C)成分を前記使用時の濃度範囲で含有する組成物として、用いられる。したがって、本発明により、(A)成分0.1〜2.0質量%、(B)成分0.01〜1.0質量%、(C)成分0.02〜0.5質量%、及び水を含有する殺菌剤組成物を、10℃以上60℃以下の温度にして対象物に接触させる殺菌方法が提供される。本発明の殺菌剤組成物の対象物への接触は、適当な希釈液を接触させることにより行われるが、希釈液と対象物は充分に接触させることが重要で、浸漬する方法の他、ライン洗浄等の場合、通液時の流速を例えば0.1〜50リットル/分で調整する方法や通液後の滞留時間を例えば10分〜50時間で調整する方法が利用できる。浸漬する方法ではエアーバブリングや超音波を併用することもできる。またウォッシャーディスインフェクターのような医療機器洗浄機用の洗浄剤として用いることができる。 The disinfectant composition of the present invention is subjected to a disinfection method in which the composition is brought to a temperature of 10 ° C. or more and 60 ° C. or less and brought into contact with an object. At that time, the fungicide composition of the present invention is preferably used as it is or as a composition obtained by diluting a high-concentration fungicide stock solution with water as described above with the components (A) to (C). It is used as a composition containing in the concentration range at the time of use. Therefore, according to the present invention, (A) component 0.1-2.0 mass%, (B) component 0.01-1.0 mass%, (C) component 0.02-0.5 mass%, and water There is provided a sterilization method in which a sterilizing composition containing saponification is brought into contact with an object at a temperature of 10 ° C. or more and 60 ° C. or less. The contact of the disinfectant composition of the present invention with an object is carried out by bringing an appropriate diluent into contact. However, it is important to sufficiently bring the diluent into contact with the object. In the case of washing or the like, a method of adjusting the flow rate at the time of passing through, for example, 0.1 to 50 liters / minute, or a method of adjusting the residence time after passing through, for example, 10 minutes to 50 hours can be used. In the dipping method, air bubbling or ultrasonic waves can be used in combination. Moreover, it can be used as a cleaning agent for a medical device washer such as a washer disinfector.
<実施例1〜6及び比較例1〜5>
(1)細菌芽胞の殺菌効果
枯草菌(Bacillus subtilis ATCC6051)をSCD寒天培地(日本製薬株式会社製)に30℃で4週間前培養した後、寒天培地上に形成されたコロニーを適量かきとって1mLの滅菌水に懸濁し、検鏡して細菌芽胞(以下、芽胞という)の形成を確認した。この懸濁液を2回遠心洗浄した後、適量の滅菌水で108〜109cfu/mLの菌濃度に調整した。
<Examples 1-6 and Comparative Examples 1-5>
(1) Bactericidal effect of bacterial spores After Bacillus subtilis ATCC6051 is pre-cultured on an SCD agar medium (manufactured by Nippon Pharmaceutical Co., Ltd.) at 30 ° C. for 4 weeks, an appropriate amount of colonies formed on the agar medium are scraped off. The suspension was suspended in 1 mL of sterilized water and microscopically confirmed to form bacterial spores (hereinafter referred to as spores). This suspension was subjected to centrifugal washing twice, and then adjusted to a bacterial concentration of 10 8 to 10 9 cfu / mL with an appropriate amount of sterilized water.
この芽胞懸濁液の0.1mLを、表1の殺菌剤組成物1.9mLに接種し、表1の殺菌条件で作用させた。所定の温度で、所定の時間作用させた後に、この混合液の0.1mLを、リン酸緩衝液(pH6.4)1.9mLに混合、不活化した。この不活化液0.4mLを直径9cmの標準寒天培地2枚に(1枚に0.2mL)塗抹して、35℃で24時間培養して、2枚の培地上に形成される全コロニー数をカウントすることで残存生菌数を測定した。コロニーが観察されない時は、検出限界の50未満とした。結果を表1に示す。なお、表1の殺菌剤組成物の残部は水である。 0.1 mL of this spore suspension was inoculated into 1.9 mL of the bactericidal composition shown in Table 1 and allowed to act under the bactericidal conditions shown in Table 1. After acting for a predetermined time at a predetermined temperature, 0.1 mL of this mixed solution was mixed with 1.9 mL of phosphate buffer (pH 6.4) and inactivated. 0.4 ml of this inactivation solution is smeared on two standard agar media with a diameter of 9 cm (0.2 ml per plate) and cultured at 35 ° C. for 24 hours, and the total number of colonies formed on the two media By counting the number of remaining viable bacteria. When no colony was observed, the detection limit was set to less than 50. The results are shown in Table 1. The balance of the fungicide composition in Table 1 is water.
(2)カビ胞子の殺菌効果
黒コウジカビ(Aspergillus niger IFO6341)をポテトデキストロース寒天培地(日本製薬株式会社製)に25℃で4週間前培養した。培地上に発生した菌体をかき取って、ガラスホモジナイザーを使って約5mLの滅菌水に均一に懸濁させた。この懸濁液を2回遠心洗浄した後、適量の滅菌水で107〜108cfu/mLの菌濃度に調整した。
(2) Fungicidal effect of mold spores Black Aspergillus niger IFO6341 was pre-cultured on potato dextrose agar medium (manufactured by Nippon Pharmaceutical Co., Ltd.) at 25 ° C. for 4 weeks. The microbial cells generated on the medium were scraped and suspended uniformly in about 5 mL of sterile water using a glass homogenizer. This suspension was centrifugally washed twice, and then adjusted to a bacterial concentration of 10 7 to 10 8 cfu / mL with an appropriate amount of sterilized water.
この胞子懸濁液の0.1mLを、表1に示す殺菌剤組成物1.9mLに接種し、表1の殺菌条件で作用させた。所定の温度で、所定の時間作用させた後に、この混合液の0.1mLを、リン酸緩衝液(pH6.4)1.9mLに混合、不活化した。この不活化液0.4mLを直径9cmの標準寒天培地2枚に(1枚に0.2mL)塗抹して、25℃で72時間培養して、2枚の培地上に形成される全コロニー数をカウントすることで残存生菌数を測定した。コロニーが観察されない時は、検出限界の50未満とした。結果を表1に示す。 0.1 mL of this spore suspension was inoculated into 1.9 mL of the bactericidal composition shown in Table 1, and allowed to act under the bactericidal conditions shown in Table 1. After acting for a predetermined time at a predetermined temperature, 0.1 mL of this mixed solution was mixed with 1.9 mL of phosphate buffer (pH 6.4) and inactivated. 0.4 ml of this inactivation solution is smeared on two standard agar media with a diameter of 9 cm (0.2 ml per plate) and cultured at 25 ° C. for 72 hours to obtain the total number of colonies formed on the two media. By counting the number of remaining viable bacteria. When no colony was observed, the detection limit was set to less than 50. The results are shown in Table 1.
(3)たんぱく質汚れ及び炭酸カルシウムの除去性
ラインの一部を下記の条件で汚染させたシリコンチューブに置き換え、ポンプを介して液を循環できるようにループ状にラインを組み立て、表1の殺菌剤組成物を所定の条件で循環させた。循環条件は、循環時間40分、循環温度25℃、循環流量500mL/分とした。循環後、汚染させたシリコンチューブを取り外し、内部の汚染度を評価した。結果を表1に示す。
(3) Removal of protein stains and calcium carbonate Replace a part of the line with a silicon tube contaminated under the following conditions, assemble the line in a loop so that the liquid can be circulated through the pump, and the disinfectant listed in Table 1 The composition was circulated under predetermined conditions. The circulation conditions were a circulation time of 40 minutes, a circulation temperature of 25 ° C., and a circulation flow rate of 500 mL / min. After circulation, the contaminated silicon tube was removed and the internal contamination degree was evaluated. The results are shown in Table 1.
*シリコンチューブの汚染条件
内径6mmのシリコンチューブ約40cmに標準的な透析液〔扶桑薬品工業(株)、キンダリー液AF−1号〕を充満させて、横置きにして3日間静置した。炭酸カルシウムの白い結晶が析出したのを確認して透析液を廃棄した。更に馬血液の約2mLを同じシリコンチューブの内面に添加して、60℃で2時間横置きにして馬血液を熱劣化させ固着させた。
* Contamination condition of silicon tube A standard dialysis solution (Fuso Pharmaceutical Co., Ltd., kinderly solution AF-1) was filled in about 40 cm of a silicon tube having an inner diameter of 6 mm, and left to stand for 3 days. After confirming the precipitation of white crystals of calcium carbonate, the dialysate was discarded. Further, about 2 mL of horse blood was added to the inner surface of the same silicone tube, and the horse blood was left to stand at 60 ° C. for 2 hours to thermally deteriorate and fix.
*たんぱく質汚れの評価法
洗浄終了後シリコンチューブを取り外し、血液汚れの部分を含む約5cmを縦に割断し、アミドブラック染色法でたんぱく質付着状態を、目視で下記の4段階で評価した。
目視評価基準:評価対象面の染色程度
1.「なし」=染色されない
2.「少し」=薄い青色
3.「中程度」=青色
4.「多い」=濃い青色
* Evaluation method for protein stains After completion of washing, the silicon tube was removed, about 5 cm including the blood stain portion was cut vertically, and the protein adhesion state was visually evaluated by the following four steps by the amide black staining method.
Visual evaluation criteria: Degree of staining of the evaluation target surface “None” = not stained “Slightly” = light blue “Medium” = blue "Many" = dark blue
*炭酸カルシウム付着量の評価法
たんぱく質汚れの評価に用いた残りのシリコンチューブ約30cmの内部に0.1N塩酸溶液を満たし、付着している炭酸カルシウム分を溶出し、その溶出液のCa濃度を測定して、付着炭酸カルシウム量を求めた。シリコンチューブ約30cmの内部の容積に対して溶出したCaCO3の量をmg/Lの単位で示した。
* Evaluation method of calcium carbonate adhesion amount The remaining silicon tube used for the evaluation of protein stains is filled with 0.1N hydrochloric acid solution to elute the adhering calcium carbonate, and the Ca concentration of the eluate is determined. Measurement was made to determine the amount of adhered calcium carbonate. The amount of CaCO 3 eluted with respect to the internal volume of about 30 cm of the silicon tube is shown in units of mg / L.
表中の(C)成分は以下のものである。
・サニゾールC:塩化ベンザルコニウム(花王(株)製)〔式(1)のR1がベンジル基、R2、R3がメチル基、R4が炭素数12〜16の混合アルキル基である化合物〕
・コータミン60W:塩化セチルトリメチルアンモニウム(花王(株)製)〔式(1)のR1、R2、R3がメチル基、R4が炭素数16のアルキル基である化合物〕
The component (C) in the table is as follows.
Sanisole C: benzalkonium chloride (manufactured by Kao Corporation) [wherein R 1 in formula (1) is a benzyl group, R 2 and R 3 are methyl groups, and R 4 is a mixed alkyl group having 12 to 16 carbon atoms. Compound〕
Cotamine 60W: Cetyltrimethylammonium chloride (manufactured by Kao Corporation) [compound in which R 1 , R 2 and R 3 in formula (1) are methyl groups and R 4 is an alkyl group having 16 carbon atoms]
<実施例7〜9>
DL−リンゴ酸40.0gを36.0gのイオン交換水に溶解させる。そこへ97%濃硫酸とサニゾールC(有効分50.2質量%)を各々4.12gと15.9gを添加溶解させた。イオン交換水を足して全体を100.0gとして高濃度の殺菌剤原液を得た。この殺菌剤原液は、−5℃と60℃で2ヶ月間保存しても沈殿などを生じることなく安定であった。この高濃度の殺菌剤原液を30倍、40倍及び50倍希釈して得られる殺菌剤組成物を用いて、実施例1等と同様の試験を行った。結果を表2に示す。
<Examples 7 to 9>
40.0 g of DL-malic acid is dissolved in 36.0 g of ion-exchanged water. Thereto, 97% concentrated sulfuric acid and Sanisole C (effective content 50.2% by mass) were added and dissolved in 4.12 g and 15.9 g, respectively. Ion exchange water was added to make the whole 100.0 g to obtain a high concentration bactericide stock solution. This stock solution of bactericide was stable without precipitation or the like even when stored at −5 ° C. and 60 ° C. for 2 months. A test similar to Example 1 was conducted using a bactericide composition obtained by diluting this high-concentration bactericide solution 30 times, 40 times and 50 times. The results are shown in Table 2.
表1と表2の結果より、本発明の殺菌剤組成物は、殺菌性に優れ、同時に炭酸カルシウムとたんぱく質汚れを効果的に除去できる殺菌剤組成物であることが示された。 From the results of Tables 1 and 2, it was shown that the fungicide composition of the present invention is a fungicide composition that has excellent bactericidal properties and can effectively remove calcium carbonate and protein stains at the same time.
Claims (11)
R1R2R3R4N+X- 式(1)
〔式(1)中、R1、R2、R3及びR4のうち少なくとも1つは、アルコキシル基、アルカノイルアミノ基又はアルカノイルオキシ基で置換されていてもよい総炭素数8〜28のアルキル基又はアルケニル基を示し、残余はフェニル基、ベンジル基、炭素数1〜5のアルキル基、及び−(R5O)mH(ここでR5は炭素数2〜3のアルキレン基を示し、mは2〜40の数を示す)から選ばれる基を示す。X-はハロゲン原子又は有機性のアニオン基である。〕 The disinfectant composition according to any one of claims 1 to 7, wherein (C) the quaternary ammonium salt is selected from a benzethonium salt, an alkylpyridinium salt, or a compound represented by the following general formula (1).
R 1 R 2 R 3 R 4 N + X - wherein (1)
[In the formula (1), at least one of R 1 , R 2 , R 3 and R 4 is alkyl having a total carbon number of 8 to 28 which may be substituted with an alkoxyl group, an alkanoylamino group or an alkanoyloxy group. A group or an alkenyl group, the remainder being a phenyl group, a benzyl group, an alkyl group having 1 to 5 carbon atoms, and — (R 5 O) m H (wherein R 5 represents an alkylene group having 2 to 3 carbon atoms, m represents a group selected from 2 to 40). X − represents a halogen atom or an organic anionic group. ]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007218888A JP5095308B2 (en) | 2007-08-24 | 2007-08-24 | Disinfectant composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007218888A JP5095308B2 (en) | 2007-08-24 | 2007-08-24 | Disinfectant composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009051756A true JP2009051756A (en) | 2009-03-12 |
JP5095308B2 JP5095308B2 (en) | 2012-12-12 |
Family
ID=40503163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007218888A Active JP5095308B2 (en) | 2007-08-24 | 2007-08-24 | Disinfectant composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5095308B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011212521A (en) * | 2010-03-31 | 2011-10-27 | Aquas Corp | Scale remover and scale removing method |
JP2014172894A (en) * | 2013-03-12 | 2014-09-22 | Separator System Kogyo Kk | Aerosol type edible sterilizing agent |
JP2015137240A (en) * | 2014-01-21 | 2015-07-30 | フマキラー株式会社 | Herbicide and herbicidal method |
KR101853076B1 (en) * | 2011-11-08 | 2018-04-27 | 한국생명공학연구원 | Antiviral or antimicrobial composition comprising curcumin |
JP2019031490A (en) * | 2017-08-09 | 2019-02-28 | 攝津製油株式会社 | Sterilization method of bacterial spore |
JP2020502055A (en) * | 2016-12-13 | 2020-01-23 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Biocidal composition for use in laundry washing processes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004315537A (en) * | 2003-04-17 | 2004-11-11 | L'air Liquide Sante Internatl | Method for chemical and thermal sterilization |
JP2006206535A (en) * | 2005-01-31 | 2006-08-10 | Osaka Sasaki Chemical Co Ltd | Washing disinfectant for medical equipment |
-
2007
- 2007-08-24 JP JP2007218888A patent/JP5095308B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004315537A (en) * | 2003-04-17 | 2004-11-11 | L'air Liquide Sante Internatl | Method for chemical and thermal sterilization |
JP2006206535A (en) * | 2005-01-31 | 2006-08-10 | Osaka Sasaki Chemical Co Ltd | Washing disinfectant for medical equipment |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011212521A (en) * | 2010-03-31 | 2011-10-27 | Aquas Corp | Scale remover and scale removing method |
KR101853076B1 (en) * | 2011-11-08 | 2018-04-27 | 한국생명공학연구원 | Antiviral or antimicrobial composition comprising curcumin |
JP2014172894A (en) * | 2013-03-12 | 2014-09-22 | Separator System Kogyo Kk | Aerosol type edible sterilizing agent |
JP2015137240A (en) * | 2014-01-21 | 2015-07-30 | フマキラー株式会社 | Herbicide and herbicidal method |
JP2020502055A (en) * | 2016-12-13 | 2020-01-23 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Biocidal composition for use in laundry washing processes |
JP7023949B2 (en) | 2016-12-13 | 2022-02-22 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Biocidal composition for use in the laundry washing process |
JP2019031490A (en) * | 2017-08-09 | 2019-02-28 | 攝津製油株式会社 | Sterilization method of bacterial spore |
Also Published As
Publication number | Publication date |
---|---|
JP5095308B2 (en) | 2012-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6239644B2 (en) | disinfectant | |
JP4950131B2 (en) | Antimicrobial system and method | |
JPWO2006057311A1 (en) | Hypochlorous acid type germicide composition | |
JP5095308B2 (en) | Disinfectant composition | |
JPH08502047A (en) | Bactericidal compositions and methods | |
US9433643B2 (en) | Microbicidal composition comprising hydrogen peroxide and aminocarboxylic acids | |
JP2017522378A (en) | Bactericidal composition containing silver ion and quaternary salt | |
JP5186254B2 (en) | Amoeba disinfectant and amoeba suppression method | |
JP4963055B2 (en) | Disinfectant composition | |
JP4733851B2 (en) | Amoeba disinfectant, amoeba control method and legionella eradication method | |
US6331514B1 (en) | Sterilizing and disinfecting compound | |
JP2004002229A (en) | Method for sterilization | |
JP7058490B2 (en) | Antibacterial composition that suppresses viruses, bacteria and fungi | |
US20070286907A1 (en) | Germicide composition | |
JP3607652B2 (en) | Disinfectant composition | |
RU2569761C2 (en) | Disinfectant composition | |
JP2013213017A (en) | Peracetic acid-including microbicidal composition | |
JP4228175B2 (en) | Disinfectant composition liquid and disinfecting method | |
JP5784964B2 (en) | Disinfectant composition and disinfecting method | |
JP2010235509A (en) | Microorganism controlling agent and microorganism controlling method | |
JP5596106B2 (en) | Amoeba suppression method | |
JP2002128618A (en) | Germicide composition | |
JP2004010564A (en) | Germicidal composition | |
JP2002145710A (en) | Disinfectant composition | |
JP5755923B2 (en) | Biofilm peeling method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100608 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120424 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120508 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120706 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120711 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120803 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120918 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120919 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5095308 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150928 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |